Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Joel Gelfand MD, MSCE, FAAD

Joel M. Gelfand MD, MSCE, FAAD

James J. Leyden Professor of Dermatology and of Epidemiology; Vice Chair for Clinical Research (Dermatology); Director, Psoriasis and Phototherapy Treatment Center; Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania

Joel M. Gelfand, MD, MSCE is Professor of Dermatology and Epidemiology (tenured) at the University of Pennsylvania’s Perelman School of Medicine. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 100 scientific publications (cited over 7000 times, H index 38) which appear in journals such as JAMA, BMJ, European Heart Journal, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association’s Psoriasis Achievement Award, PENN’s Marjorie Bowman Award, and is an elected member of the American Society for Clinical Investigation.